Perinatal HIV-1 transmission -: Interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort

被引:201
作者
Mandelbrot, L
Le Chenadec, J
Berrebi, A
Bongain, M
Bénifla, JL
Delfraissy, JF
Blanche, S
Mayaux, MJ
机构
[1] Hop Cochin Port Royal, Serv Gynecol Obstet 1, F-75014 Paris, France
[2] INSERM, U149, Paris, France
[3] INSERM, U292, Le Kremlin Bicetre, France
[4] Hop La Grave, Serv Gynecol Obstet, Toulouse, France
[5] Hop Archet 2, Serv Gynecol Obstet, Nice, France
[6] Hop Bichat Claude Bernard, Serv Gynecol Obstet, F-75877 Paris, France
[7] Hop Kremlin Bicetre, Serv Med Interne, Le Kremlin Bicetre, France
[8] Hop Necker Enfants Malad, Serv Pediat, Paris, France
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1998年 / 280卷 / 01期
关键词
D O I
10.1001/jama.280.1.55
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context.-It is unclear whether elective cesarean delivery may have a protective effect against the transmission of human immunodeficiency virus 1 (HIV-1). Objective.-To investigate whether mode of delivery has an impact on perinatal HIV-1 transmission in the presence of zidovudine prophylaxis. Design.-A prospective cohort study. Setting.-The 85 perinatal centers in the French Perinatal Cohort, from 1985 to 1996. Patients.-A total of 2834 singleton children born to mothers with HIV-1 infection. Main Outcome Measure.-Human immunodeficiency virus 1 infection of the infant. Results.-No zidovudine was used in 1917 pregnancies and zidovudine prophylaxis was used in 902 pregnancies. Cesarean deliveries were performed in 10.9% on an emergent basis and in 8.3% electively, prior to labor or membrane rupture. In 1917 mothers who did not receive zidovudine, of 1877 with information on mode of delivery, 17.2% transmitted HIV-1 to their child. Risk factors statistically significantly associated with transmission were maternal p24 antigenemia, cervicovaginal infections during pregnancy, amniotic fluid color, and rupture of membranes 4 hours or more before delivery. Mode of delivery was not related to transmission. in 902 mothers receiving zidovudine, transmission was 6.4% in 872 with information on mode of delivery, and elective cesarean delivery (n = 133) was associated with a lower transmission rate than emergent cesarean or vaginal delivery (0.8%, 11.4%, and 6.6%, respectively; P=.002). In a multivariate analysis of all mother-child pairs, including obstetrical risk factors, maternal p24 antigenemia, and zidovudine prophylaxis, interaction between mode of delivery and zidovudine prophylaxis was significant (P=.007). In the multivariate analysis of pregnancies with zidovudine prophylaxis, factors related to transmission rate were maternal p24 antigenemia, amniotic fluid color, and mode of delivery. Adjusted odds ratios (95% confidence intervals) were 1.6 (0.7-3.6) for emergent cesarean delivery and 0.2 (0.0-0.9) for elective cesarean delivery (P =.04) in comparison with vaginal delivery. Conclusions.-We observed an interaction between zidovudine prophylaxis and elective cesarean delivery in decreasing transmission of HIV-1 from mother to child. This observation may have clinical implications for prevention.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 40 条
  • [11] Fiscus SA, 1996, JAMA-J AM MED ASSOC, V275, P1483, DOI 10.1001/jama.275.19.1483
  • [12] HOGBERG U, 1994, OBSTET GYNECOL, V84, P240
  • [13] Prevention of vertical HIV transmission:: additive protective effect of elective Cesarean section and zidovudine prophylaxis
    Kind, C
    Rudin, C
    Siegrist, CA
    Wyler, CA
    Biedermann, K
    Lauper, U
    Irion, O
    Schüpbach, J
    Nadal, D
    [J]. AIDS, 1998, 12 (02) : 205 - 210
  • [14] KIND C, 1995, EUR J PEDIATR, V154, P542, DOI 10.1007/BF02074831
  • [15] Timing of maternal-infant HIV transmission: Associations between intrapartum factors and early polymerase chain reaction results
    Kuhn, L
    Abrams, EJ
    Matheson, PB
    Thomas, PA
    Lambert, G
    Bamji, M
    Greenberg, B
    Steketee, RW
    Thea, DM
    Beatrice, ST
    Chiasson, MA
    DeBernardo, E
    Hutchison, S
    McVeigh, K
    Oleszko, W
    Punsalang, A
    Alford, T
    Betre, A
    Cappelli, M
    Carrasquillio, N
    Cruz, N
    Floyd, J
    FoyeSousou, V
    Jessop, DJ
    Macias, L
    Ng, D
    Nelson, K
    Rios, J
    Pliner, V
    Rosenbluth, L
    Hodge, R
    Tadros, H
    Weedon, J
    Young, S
    Zhang, ZR
    Courtland, R
    Daligadu, M
    Hoover, W
    Lopez, D
    Pollack, H
    Krasinski, K
    Belmore, A
    Champion, S
    Freedland, C
    Lovich, S
    Prince, P
    Rogers, A
    Suarez, M
    Chow, J
    Kaul, A
    [J]. AIDS, 1997, 11 (04) : 429 - 435
  • [16] MATERNAL-INFANT HIV TRANSMISSION AND CIRCUMSTANCES OF DELIVERY
    KUHN, L
    STEIN, ZA
    THOMAS, PA
    SINGH, T
    TSAI, WY
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1994, 84 (07) : 1110 - 1115
  • [17] Obstetrical factors and the transmission of human immunodeficiency virus type I from mother to child
    Landesman, SH
    Kalish, LA
    Burns, DN
    Minkoff, H
    Fox, HE
    Zorrilla, C
    Garcia, P
    Fowler, MG
    Mofenson, L
    Tuomala, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (25) : 1617 - 1623
  • [18] Least microtransfusion from mother to fetus in elective cesarean delivery
    Lin, HH
    Kao, JH
    Hsu, HY
    Mizokami, M
    Hirano, K
    Chen, DS
    [J]. OBSTETRICS AND GYNECOLOGY, 1996, 87 (02) : 244 - 248
  • [19] HIV-1 detection in cervicovaginal secretions during pregnancy
    LoussertAjaka, I
    Mandelbrot, L
    Delmas, MC
    Bastian, H
    Benifla, JL
    Farfara, I
    deVincenzi, I
    Matheron, S
    Simon, F
    BrunVezinet, F
    [J]. AIDS, 1997, 11 (13) : 1575 - 1581
  • [20] Mandelbrot L, 1996, AM J OBSTET GYNECOL, V175, P661